A new study has for the first time elucidated the gut-liver immune regulatory axis jointly maintained by intestinal commensal ...

Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and ...

An innovative method known as ONCOTECH has been developed by researchers to physically attach oncolytic adenoviruses to T-cell surfaces through the interaction of antigens and receptors. To accomplish ...

The impact of proton-pump inhibitor use on the incidence and severity of gastrointestinal toxicity to checkpoint inhibition. A multi-centre, single arm, phase 2 trial of pembrolizumab in ...

Scientists at the University of Science and Technology of China have identified a signaling chain that starts with gut bacteria, triggers serotonin release from intestinal cells, and ends with liver ...

Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic ...

What is the work you’re leading at KaliVir as CEO? Our goal is to develop viral treatments that can reach and eliminate cancer cells in the body, bringing us closer to a cure for all cancer patients.

SAN DIEGO, June 23, 2023 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi”), a clinical-stage biotechnology company that is pioneering the development of allogeneic cell-based delivery of ...

Cancer research has long looked at bacteria and viruses as separate tools for therapy. Now, researchers are showing that the two can actually work better together. A team of scientists has built a new ...

DUBLIN--(BUSINESS WIRE)--The "Oncolytic Virus Immunotherapy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Oncolytic Virus Immunotherapy ...